Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin. BJS 2018; 105: 96-105.
Published: 2nd November 2017
Authors: D. Verver, M. F. Madu, C. M. C. Oude Ophuis, M. Faut, J. H. W. de Wilt, J. J. Bonenkamp et al.
The optimal extent of groin completion lymph node dissection (CLND) (inguinal or ilioinguinal dissection) in patients with melanoma is controversial. The aim of this study was to evaluate whether the extent of groin CLND after a positive sentinel node biopsy (SNB) is associated with improved outcome.
Data from all sentinel node‐positive patients who underwent groin CLND at four tertiary melanoma referral centres were retrieved retrospectively. Baseline patient and tumour characteristics were collected for descriptive statistics, survival analyses and Cox proportional hazards regression analyses.
In total, 255 patients were included, of whom 137 (53·7 per cent) underwent inguinal dissection and 118 (46·3 per cent) ilioinguinal dissection. The overall CLND positivity rate was 18·8 per cent; the inguinal positivity rate was 15·5 per cent and the pelvic positivity rate was 9·3 per cent. The pattern of recurrence, and 5‐year melanoma‐specific survival, disease‐free survival and distant‐metastasis free survival rates were similar for both dissection types, even for patients with a positive CLND result. Cox regression analysis showed that type of CLND was not associated with disease‐free or melanoma‐specific survival.
There was no significant difference in recurrence pattern and survival rates between patients undergoing inguinal or ilioinguinal dissection after a positive SNB, even after stratification for a positive CLND result. An inguinal dissection is a safe first approach as CLND in patients with a positive SNB.Read more
You may also be interested in
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra‐appendicular origin.
Authors: J.‐B. Delhorme, F. Severac, G. Averous, O. Glehen, G. Passot, N. Bakrin et al.
Notes: Survival similar
Randomized clinical trial
Randomized clinical trial of intraoperative parathyroid gland angiography with indocyanine green fluorescence predicting parathyroid function after thyroid surgery.
Authors: J. Vidal Fortuny, S. M. Sadowski, V. Belfontali, S. Guigard, A. Poncet, F. Ris et al.
Notes: Simplifies post‐op monitoring
Authors: J. Church
Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis. BJS 2018; 105: 270-278.
Authors: H. I. Kim, T. H. Kim, J.‐H. Choe, J.‐H. Kim, J. S. Kim, Y. N. Kim et al.
Notes: Volume is key
Effect of parathyroidectomy on quality of life and non‐specific symptoms in normocalcaemic primary hyperparathyroidism. BJS 2018; 105: 223-229.
Authors: S. Bannani, N. Christou, C. Guérin, A. Hamy, F. Sebag, M. Mathonnet et al.
Notes: Little improvement
Systematic review and simulation study of ignoring clustered data in surgical trials. BJS 2018; 105: 182-191.
Authors: S. Dell‐Kuster, R. A. Droeser, J. Schäfer, V. Gloy, H. Ewald, S. Schandelmaier et al.
Notes: A statistical lesson
Authors: S. A. Liu, C. C. Wang, R. S. Jiang, W. Y. Wang, J. C. Lin
Notes: Microsatellite instability predicts recurrence
Authors: A. M. Altman, J. Y. C. Hui, T. M. Tuttle
Notes: Can be significant
Authors: H. M. Rossitti, P. Söderkvist, O. Gimm
Notes: Genotype dictates type of surgery
Long‐term outcome of prophylactic thyroidectomy in children carrying RET germline mutations. BJS 2018; 105: e150-e157.
Authors: A. Machens, M. Elwerr, K. Lorenz, F. Weber, H. Dralle
Notes: Early surgery better
Authors: P. M. Ferguson, G. V. Long, R. A. Scolyer, J. F. Thompson
Notes: Great advances